These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 34883342)
21. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level. Fujimoto M; Oka T; Murata T; Hori M; Ozaki H Eur J Pharmacol; 2009 Jan; 602(2-3):432-8. PubMed ID: 19059394 [TBL] [Abstract][Full Text] [Related]
22. HMG-CoA reductase inhibitors reduce interleukin-6 synthesis in human vascular smooth muscle cells. Ito T; Ikeda U; Shimpo M; Ohki R; Takahashi M; Yamamoto K; Shimada K Cardiovasc Drugs Ther; 2002 Mar; 16(2):121-6. PubMed ID: 12090904 [TBL] [Abstract][Full Text] [Related]
26. Saucerneol F inhibits tumor necrosis factor-α and IL-6 production by suppressing Fyn-mediated pathways in FcεRI-mediated mast cells. Lu Y; Piao D; Zhang H; Li X; Chao GH; Park SJ; Chang YC; Kim CH; Murakami M; Jung SH; Choi JH; Son JK; Chang HW Food Chem Toxicol; 2013 Sep; 59():696-702. PubMed ID: 23851146 [TBL] [Abstract][Full Text] [Related]
27. Role of Ca(2+) on TNF-alpha and IL-6 secretion from RBL-2H3 mast cells. Jeong HJ; Hong SH; Lee DJ; Park JH; Kim KS; Kim HM Cell Signal; 2002 Jul; 14(7):633-9. PubMed ID: 11955956 [TBL] [Abstract][Full Text] [Related]
29. IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia. Ranjitkar S; Krajewski D; Garcia C; Tedeschi C; Polukort SH; Rovatti J; Mire M; Blesso CN; Jellison E; Schneider SS; Ryan JJ; Mathias CB J Immunol; 2024 May; 212(9):1407-1419. PubMed ID: 38497670 [TBL] [Abstract][Full Text] [Related]
30. Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: role for mast cell tumor necrosis factor-alpha and transforming growth factor-beta 1. Kendall JC; Li XH; Galli SJ; Gordon JR J Allergy Clin Immunol; 1997 Jan; 99(1 Pt 1):113-23. PubMed ID: 9003219 [TBL] [Abstract][Full Text] [Related]
31. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells. Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887 [TBL] [Abstract][Full Text] [Related]
32. Fluvastatin protects neuronal cells from hydrogen peroxide-induced toxicity with decreasing oxidative damage and increasing PI3K/Akt/mTOR signalling. Wang M; Wang J; Liu M; Chen G J Pharm Pharmacol; 2021 Mar; 73(4):515-521. PubMed ID: 33793833 [TBL] [Abstract][Full Text] [Related]
33. Effects of various statins on cytokine-dependent growth and IgE-dependent release of histamine in human mast cells. Krauth MT; Majlesi Y; Sonneck K; Samorapoompichit P; Ghannadan M; Hauswirth AW; Baghestanian M; Schernthaner GH; Worda C; Müller MR; Sperr WR; Valent P Allergy; 2006 Mar; 61(3):281-8. PubMed ID: 16436135 [TBL] [Abstract][Full Text] [Related]
34. Cardioprotective cytokine interleukin-33 is up-regulated by statins in human cardiac tissue. Pentz R; Kaun C; Thaler B; Stojkovic S; Lenz M; Krychtiuk KA; Zuckermann A; Huber K; Wojta J; Hohensinner PJ; Demyanets S J Cell Mol Med; 2018 Dec; 22(12):6122-6133. PubMed ID: 30216659 [TBL] [Abstract][Full Text] [Related]
39. Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein. Wang HR; Li JJ; Huang CX; Jiang H Clin Chim Acta; 2005 Mar; 353(1-2):53-60. PubMed ID: 15698590 [TBL] [Abstract][Full Text] [Related]